Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment

Pediatric Pulmonology

Volumn 51, Issue 2, 2016, Pages 203-216

  Giovannini Chami, Lisa ^a,b   Blanc, Sibylle ^a   Hadchouel, Alice ^c,d   Baruchel, André ^d,e,f   Boukari, Rachida ^d   Dubus, Jean Christophe ^g   Fayon, Michael ^h,i   Le Bourgeois, Muriel ^c   Nathan, Nadia ^j,k   Albertini, Marc ^a,b   Clément, Annick ^j,k   De Blic, Jacques ^c,d  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f CHU Mustapha   (Algeria)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ Centre of Clinical Investigation Clinical Epidemiology   (France)

^j SERVICE DE DERMATOLOGIE   (France)

^k SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

allergic bronchopulmonary aspergillosis; drug induced eosinophilic pneumonia; eosinophilic granulomatosis with polyangiitis; hypereosinophilic asthma; hypereosinophilic syndrome; idiopathic acute eosinophilic pneumonia; idiopathic chronic eosinophilic pneumonia; interstitial lung diseases; tropical eosinophilic pneumonia; visceral larva migrans syndrome

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; AZITHROMYCIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAPTOPRIL; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DICLOFENAC; ETHAMBUTOL; FENBUFEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; MINOCYCLINE; NAPROXEN; OMALIZUMAB; OXICAM DERIVATIVE; PENICILLIN DERIVATIVE; PHENYLBUTAZONE; PIROXICAM; PREDNISOLONE; PYRIMETHAMINE; SULFONAMIDE; SULINDAC; TRYPTOPHAN; UNINDEXED DRUG;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANAMNESIS; ARTICLE; ASTHMA; CHILD; CHURG STRAUSS SYNDROME; DIAGNOSTIC APPROACH ROUTE; EOSINOPHILIA; HUMAN; HYPEREOSINOPHILIC ASTHMA; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA; IDIOPATHIC CHRONIC EOSINOPHILIC PNEUMONIA; INTERSTITIAL PNEUMONIA; LOEFFLER PNEUMONIA; LOW DRUG DOSE; LUNG LAVAGE; PARASITOSIS; PRIORITY JOURNAL; PROGNOSIS; ADOLESCENT; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CHURG-STRAUSS SYNDROME; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; LEUKOCYTE COUNT; LUNG DISEASES, PARASITIC; PRESCHOOL CHILD; PULMONARY EOSINOPHILIA;

ADOLESCENT; ADRENAL CORTEX HORMONES; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BRONCHOALVEOLAR LAVAGE; CHILD; CHILD, PRESCHOOL; CHURG-STRAUSS SYNDROME; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LUNG DISEASES, PARASITIC; PROGNOSIS; PULMONARY EOSINOPHILIA;

EID: 84955419386     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23368     Document Type: Article

References (76)

1. Nathan N, Taam RA, Epaud R, Delacourt C, Deschildre A, Reix P, Chiron R, de Pontbriand U, Brouard J, Fayon M, et al., A national internet-linked based database for pediatric interstitial lung diseases: the French network. Orphanet J Rare Dis 2012; 7: 40.
2. Cottin V, Cordier JF,. Eosinophilic pneumonias. Allergy 2005; 60: 841-857.
3. Giovannini-Chami L, Hadchouel A, Nathan N, Bremont F, Dubus JC, Fayon M, Houdouin V, Berlioz-Baudoin M, Feret V, Leblanc T, et al., Idiopathic eosinophilic pneumonia in children: the French experience. Orphanet J Rare Dis 2014; 9: 28.
4. Sauvaget E, Dellamonica J, Arlaud K, Sanfiorenzo C, Bernardin G, Padovani B, Viard L, Dubus JC,. Idiopathic acute eosinophilic pneumonia requiring ECMO in a teenager smoking tobacco and cannabis. Pediatr Pulmonol 2010; 45: 1246-1249.
5. Johkoh T, Muller NL, Akira M, Ichikado K, Suga M, Ando M, Yoshinaga T, Kiyama T, Mihara N, Honda O, et al., Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000; 216: 773-780.
6. Allen JN, Davis WB,. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150: 1423-1438.
7. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, Savioli L,. Control of neglected tropical diseases. N Engl J Med 2007; 357: 1018-1027.
8. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, Hotez PJ,. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006; 367: 1521-1532.
9. Hotez PJ, Gurwith M,. Europe's neglected infections of poverty. Int J Infect Dis 2011; 15: e611-e619.
10. Hotez PJ,. Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2008; 2: e256.
11. Krolewiecki AJ, Lammie P, Jacobson J, Gabrielli AF, Levecke B, Socias E, Arias LM, Sosa N, Abraham D, Cimino R, et al., A public health response against Strongyloides stercoralis: time to look at soil-transmitted helminthiasis in full. PLoS Negl Trop Dis 2013; 7: e2165.
12. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP,. Schistosomiasis. N Engl J Med 2002; 346: 1212-1220.
13. Liu Q, Wei F, Liu W, Yang S, Zhang X,. Paragonimiasis: an important food-borne zoonosis in China. Trends Parasitol 2008; 24: 318-323.
14. Despommier D,. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 2003; 16: 265-272.
15. Ong RK, Doyle RL,. Tropical pulmonary eosinophilia. Chest 1998; 113: 1673-1679.
16. Taylor MJ, Hoerauf A, Bockarie M,. Lymphatic filariasis and onchocerciasis. Lancet 2010; 376: 1175-1185.
17. Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser 1992; 821: 1-71.
18. Tillie-Leblond I, Tonnel AB,. Allergic bronchopulmonary aspergillosis. Allergy 2005; 60: 1004-1013.
19. Greenberger PA,. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685-692.
20. Patterson R, Greenberger PA, Radin RC, Roberts M,. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982; 96: 286-291.
21. Schwerk N, Rochwalsky U, Brinkmann F, Hansen G,. Don't forget other causes of wheeze. ABPA in a boy with asthma. A case report and review of the literature. Acta Paediatr 2011; 100: 307-310.
22. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE,. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405-414.
23. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, et al., Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37: S225-S264.
24. Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, Moss R, Denning DW,. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43: 850-873.
25. Jubin V, Ranque S, Stremler Le Bel N, Sarles J, Dubus JC,. Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol 2010; 45: 764-771.
26. Nepomuceno IB, Esrig S, Moss RB,. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999; 115: 364-370.
27. Geller DE, Kaplowitz H, Light MJ, Colin AA,. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific advisory group, investigators, and coordinators of the epidemiologic study of cystic fibrosis. Chest 1999; 116: 639-646.
28. Ritz N, Ammann RA, Casaulta Aebischer C, Schoeni-Affolter F, Schoeni MH,. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis. Eur J Pediatr 2005; 164: 577-582.
29. Agarwal R,. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805-826.
30. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K,. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998; 10: 1211-1216.
31. Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R,. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000; 30: 988-993.
32. Knutsen AP, Hutcheson PS, Slavin RG, Kurup VP,. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004; 59: 198-203.
33. Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M,. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am J Respir Crit Care Med 2006; 173: 1370-1376.
34. Latzin P, Hartl D, Regamey N, Frey U, Schoeni MH, Casaulta C,. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2008; 31: 36-42.
35. Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J,. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005; 4: 215-220.
36. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, Weinmann AJ, Tuazon CU, Judson MA, et al., A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756-762.
37. Tanou K, Zintzaras E, Kaditis AG,. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. Pediatr Pulmonol 2014; 49: 503-507.
38. Park HN, Chung BH, Pyun JE, Lee KC, Choung JT, Lim CH, Yoo Y,. Idiopathic acute eosinophilic pneumonia in a 14-month-old girl. Korean J Pediatr 2013; 56: 37-41.
39. Alp H, Daum RS, Abrahams C, Wylam ME,. Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failure. J Pediatr 1998; 132: 540-543.
40. Khemiri M, Ouederni M, Ben Mansour F, Ben Jaballah N, Barsaoui S,. [Acute respiratory failure revealing an idiopathic acute eosinophilic pneumonia: report of a pediatric case]. Ann Fr Anesth Reanim 2008; 27: 502-504.
41. Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF,. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002; 166: 1235-1239.
42. Cottin V,. Idiopathic eosinophilic pneumonias. Orphan Lung Diseases. Volume 54: European Respiratory Society Journals Ltd 2011; 118-139.
43. Rhee CK, Min KH, Yim NY, Lee JE, Lee NR, Chung MP, Jeon K,. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J 2013; 41: 402-409.
44. Rao M, Steiner P, Rose JS, Kassner EG, Kottmeier P, Steiner M,. Chronic eosinophilic pneumonia in a one-year-old child. Chest 1975; 68: 118-120.
45. Naughton M, Fahy J, FitzGerald MX,. Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients. Chest 1993; 103: 162-165.
46. O'Sullivan BP, Nimkin K, Gang DL,. A fifteen-year-old boy with eosinophilia and pulmonary infiltrates. J Pediatr 1993; 123: 660-666.
47. Oermann CM, Panesar KS, Langston C, Larsen GL, Menendez AA, Schofield DE, Cosio C, Fan LL,. Pulmonary infiltrates with eosinophilia syndromes in children. J Pediatr 2000; 136: 351-358.
48. Wubbel C, Fulmer D, Sherman J,. Chronic eosinophilic pneumonia: a case report and national survey. Chest 2003; 123: 1763-1766.
49. Tanir G, Piskin IE, Aydemir C, Adakli B, Ozmen S, Arslan Z, Ozcelik U, Uner C,. [Idiopathic chronic eosinophilic pneumonia: a case report]. Tuberk Toraks 2005; 53: 167-171.
50. Cakir E, Aksoy F, Cakir FB, Ertem T,. Chronic eosinophilic pneumonia with mucous plugs in a child. Pediatr Pulmonol 2010; 45: 1040-1042.
51. Freymond N, Kahn JE, Legrand F, Renneville A, Cordier JF, Cottin V,. Clonal expansion of T cells in patients with eosinophilic lung disease. Allergy 2011; 66: 1506-1508.
52. Cordier JF, Freymond N, Cottin V,. [Hypereosinophilic asthma]. Rev Prat 2011; 61: 325-326.
53. Jackson DJ, Sykes A, Mallia P, Johnston SL,. Asthma exacerbations: Origin, effect, and prevention. J Allergy Clin Immunol 2011; 128: 1165-1174.
54. Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF,. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1998; 77: 299-312.
55. Clement A, Nathan N, Epaud R, Fauroux B, Corvol H,. Interstitial lung diseases in children. Orphanet J Rare Dis 2010; 5: 22.
56. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
57. Clement A,. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004; 24: 686-697.
58. Yousem SA,. Eosinophilic pneumonia-like areas in idiopathic usual interstitial pneumonia. Mod Pathol 2000; 13: 1280-1284.
59. Costabel U, Teschler H, Guzman J,. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992; 5: 791-797.
60. Haslam PL, Turton CW, Lukoszek A, Salsbury AJ, Dewar A, Collins JV, Turner-Warwick M,. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980; 35: 328-339.
61. Peterson MW, Monick M, Hunninghake GW,. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987; 92: 51-56.
62. Kawabata Y, Takemura T, Hebisawa A, Ogura T, Yamaguchi T, Kuriyama T, Nagai S, Sakatani M, Chida K, Sakai F, et al., Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 2008; 52: 194-202.
63. Ishiguro T, Takayanagi N, Kurashima K, Matsushita A, Harasawa K, Yoneda K, Tsuchiya N, Miyahara Y, Yamaguchi S, Yano R, et al., Desquamative interstitial pneumonia with a remarkable increase in the number of BAL eosinophils. Intern Med 2008; 47: 779-784.
64. Allen JN, Davis WB, Pacht ER,. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990; 142: 642-647.
65. Yoshida K, Shijubo N, Koba H, Mori Y, Satoh M, Morikawa T, Abe S,. Chronic eosinophilic pneumonia progressing to lung fibrosis. Eur Respir J 1994; 7: 1541-1544.
66. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, et al., 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11.
67. Gendelman S, Zeft A, Spalding SJ,. Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort. J Rheumatol 2013; 40: 929-935.
68. Zwerina J, Eger G, Englbrecht M, Manger B, Schett G,. Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum 2009; 39: 108-115.
69. Iglesias E, Camacho Lovillo M, Delgado Pecellin, I, Lirola Cruz MJ, Falcon Neyra MD, Salazar Quero JC, Bernabeu-Wittel J, Gonzalez Valencia JP, Neth O,. Successful management of Churg-Strauss syndrome using omalizumab as adjuvant immunomodulatory therapy: first documented pediatric case. Pediatr Pulmonol 2014; 49: E78-E81.
70. Kim YK, Lee KS, Chung MP, Han J, Chong S, Chung MJ, Yi CA, Kim HY,. Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings. Eur Radiol 2007; 17: 3157-3165.
71. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, et al., Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130: 607-612 e609.
72. Katz HT, Haque SJ, Hsieh FH,. Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr 2005; 146: 134-136.
73. van Grotel M, de Hoog M, de Krijger RR, Beverloo HB, van den Heuvel-Eibrink MM,. Hypereosinophilic syndrome in children. Leuk Res 2012; 36: 1249-1254.
74. Farruggia P, Giugliano E, Russo D, Trizzino A, Lorenzatti R, Santoro A, D'Angelo P,. FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome in childhood: a case report and review of literature. J Pediatr Hematol Oncol 2014; 36: e28-e30.
75. Dulohery MM, Patel RR, Schneider F, Ryu JH,. Lung involvement in hypereosinophilic syndromes. Respir Med 2011; 105: 114-121.
76. Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, et al., Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol 2012; 130: 563-571.